AI filing briefs · archive

8-K filings in August 2025, explained

1,024 material Form 8-K filings that 799 companies we cover made with the SEC in August 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

6 of 1,024 briefs match

newest first · times in ET
WTRGEssential Utilities, Inc. Aug 1, 10:53 AM ET

Essential Utilities Q2 EPS rises to $0.38; 2025 GAAP EPS now seen above guidance

Positive guidance Written later 2.02

Essential Utilities reported second-quarter 2025 net income of $107.8 million, or $0.38 per share, up from $75.4 million, or $0.28 per share, a year earlier, on revenue of $514.9 million, up 18.5%. The company expects 2025 GAAP earnings per share above its $2.07-$2.11 guidance range due to non-recurring benefits, and it raised its quarterly dividend by 5.25%.

  • Q2 2025 net income $107.8 million, or $0.38 per share, versus $75.4 million, or $0.28 per share, in Q2 2024
  • Q2 2025 revenues $514.9 million, up 18.5% from $434.4 million; operations and maintenance expense rose to $148.5 million from $142.5 million
  • 2025 GAAP EPS expected above the $2.07-$2.11 guidance range due to non-recurring benefits; 2025 infrastructure investment expected at $1.4 to $1.5 billion
  • Quarterly dividend increased to $0.3426 per share, payable September 2, 2025, to holders of record on August 12, 2025
Read the filing on SEC.gov ↗
GWWW.W. GRAINGER, INC. Aug 1, 8:09 AM ET

Grainger Q2 sales rise 5.6% to $4.6 billion; cuts 2025 EPS guidance to $38.50-$40.25

Mixed guidance Written later 2.02

Grainger reported second-quarter 2025 sales of $4.6 billion, up 5.6%, and diluted EPS of $9.97, up 4.8% on a reported basis, while its operating margin fell 20 basis points to 14.9%. The company lowered its full-year 2025 adjusted diluted EPS guidance to $38.50-$40.25 from $39.00-$41.50, citing tariff-related headwinds, which matters to shareholders because it reduces the earnings outlook even as the quarter's top-line and per-share results grew.

  • Q2 2025 net sales were $4.6 billion, up 5.6% (5.1% on a daily, constant currency basis).
  • Diluted EPS was $9.97, up 4.8% reported and 2.2% adjusted; the company said the increase was driven primarily by fewer shares outstanding.
  • Full-year 2025 adjusted diluted EPS guidance was lowered to $38.50-$40.25 from $39.00-$41.50 as of May 1, 2025.
  • Operating cash flow was $377 million, and the company returned $336 million to shareholders through dividends and share repurchases.
Read the filing on SEC.gov ↗
CBOECboe Global Markets, Inc. Aug 1, 7:30 AM ET

Cboe Q2 net revenue rises 14% to record $587.3 million; raises revenue growth guidance

Positive guidance Written later 2.02

Cboe Global Markets reported second-quarter 2025 results on August 1, 2025, with net revenue of $587.3 million, up 14% from a year earlier, and adjusted diluted EPS of $2.46, up 14%. The company raised its 2025 organic total net revenue growth target to high single digits and lowered its adjusted operating expense guidance, which points to higher expected revenue and slightly lower expected costs for the year.

  • Net revenue of $587.3 million rose 14% from $513.8 million in Q2 2024, with Derivatives net revenue up 17%.
  • Diluted EPS of $2.23 rose 68%, primarily due to a non-recurring 2024 impairment; adjusted diluted EPS of $2.46 rose 14%.
  • 2025 organic total net revenue growth target raised to high single digits from mid to high single digits; adjusted operating expense guidance lowered to $832 million to $847 million from $837 million to $852 million.
  • Cboe plans to suspend Japanese equities operations on August 29, 2025, with normalized annual adjusted operating expense savings of $10 million to $12 million.
Read the filing on SEC.gov ↗
FLRFLUOR CORP Aug 1, 7:03 AM ET

Fluor cuts 2025 adjusted EBITDA guidance as Q2 adjusted EPS falls 49%

Negative guidance Written later 2.02

Fluor reported second-quarter 2025 revenue of $4.0 billion, down 6% from a year earlier, and adjusted EPS of $0.43, down 49%. The company lowered its 2025 adjusted EBITDA guidance to $475 million to $525 million from $575 million to $675 million, citing client hesitation around economic uncertainty, along with cost growth on three infrastructure projects. Reported GAAP net earnings of $2.5 billion were driven by a $3.2 billion pre-tax NuScale mark-to-market gain, so the adjusted figures and lower outlook are the more direct read on operating performance for shareholders.

  • Q2 revenue of $4.0 billion, down 6% year over year; adjusted EBITDA of $96 million, down 42%.
  • Adjusted EPS of $0.43 versus $0.85 a year earlier; GAAP EPS of $14.81 includes $3.2 billion in pre-tax NuScale mark-to-market gains.
  • 2025 adjusted EBITDA guidance revised to $475 million to $525 million from $575 million to $675 million; adjusted EPS guidance to $1.95 to $2.15 from $2.25 to $2.75.
  • Q2 operating cash flow was negative $21 million; backlog was $28.2 billion, down 13% from $32.3 billion a year ago.
Read the filing on SEC.gov ↗

Xenia raises 2025 guidance as second-quarter net income rises to $55.2 million

Positive guidance Written later 2.02

Xenia Hotels & Resorts reported second-quarter 2025 net income attributable to common stockholders of $55.2 million, or $0.56 per share, compared with $15.3 million, or $0.15 per share, a year earlier. The company raised its full-year 2025 guidance for Adjusted EBITDAre and Adjusted FFO, citing second-quarter outperformance and an unchanged outlook for the second half.

  • Q2 2025 Adjusted EBITDAre was $79.5 million, up 16.3% from Q2 2024; Adjusted FFO per diluted share was $0.57, up 9.6%.
  • Same-Property RevPAR rose 4.0% to $195.51 in Q2, and Same-Property Hotel EBITDA rose 22.2% to $84.0 million.
  • Full-year 2025 Adjusted EBITDAre guidance is $249 million to $263 million, and Adjusted FFO per diluted share guidance is $1.66 to $1.80.
  • In Q2 the company repurchased 2,948,912 shares for approximately $35.7 million and had $146.4 million left under its repurchase authorization.
Read the filing on SEC.gov ↗

BrightSpring raises 2025 guidance as Q2 revenue rises 29.1% to $3,148 million

Positive guidance Written later 2.02

BrightSpring Health Services reported second-quarter 2025 results on August 1, 2025, with net revenue up 29.1% and Adjusted EBITDA up 28.8%, both excluding the Community Living business. The company raised its full-year 2025 revenue and Adjusted EBITDA guidance, while net income from continuing operations was flat at $8.5 million. The planned sale of Community Living to Sevita is expected to close in the fourth quarter of 2025.

  • Q2 2025 net revenue was $3,148 million, up 29.1% from $2,438 million a year earlier.
  • Adjusted EBITDA was $143 million, up 28.8% from $111 million; net income from continuing operations was $8.5 million, flat year over year.
  • 2025 revenue guidance was raised to $12,200 million-$12,600 million, and Adjusted EBITDA guidance to $590 million-$605 million.
  • The Community Living divestiture to Sevita, announced January 20, 2025, is expected to close in Q4 2025.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.